Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
27.19
+0.29 (1.08%)
Jan 22, 2026, 3:00 PM CST
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 12.4 billion as of January 22, 2026. Its market cap has increased by 33.48% in one year.
Market Cap
12.40B
Enterprise Value
10.86B
Revenue
1.47B
Ranking
n/a
PE Ratio
162.99
Stock Price
27.19
Market Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 12.40B, an increase of 1,931.89%. That is a compound annual growth rate of 16.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 12.26B | 6.75% |
| Dec 31, 2025 | 11.49B | 30.57% |
| Dec 31, 2024 | 8.80B | -7.24% |
| Dec 29, 2023 | 9.49B | 19.17% |
| Dec 30, 2022 | 7.96B | -32.61% |
| Dec 31, 2021 | 11.81B | 28.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 406.83B |
| WuXi AppTec | 305.26B |
| Shenzhen Mindray Bio-Medical Electronics | 242.11B |
| Sichuan Biokin Pharmaceutical | 125.51B |
| Shanghai United Imaging Healthcare | 110.18B |
| Aier Eye Hospital Group | 105.32B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.31B |